Literature DB >> 1429849

Differential regulation of glucose transporter 1 and 2 mRNA expression by epidermal growth factor and transforming growth factor-beta in rat hepatocytes.

D Mischoulon1, B Rana, N Kotliar, P F Pilch, N L Bucher, S R Farmer.   

Abstract

We have examined by Northern blot analysis the expression of two members of the glucose transporter family of genes (GLUT-1 and GLUT-2) in regenerating liver and in hepatocytes cultured under various conditions. GLUT-1, although thought to be a growth-associated gene, is not expressed in normal or regenerating liver, whereas GLUT-2, a liver-specific gene, is abundant in normal liver and gradually up-regulated during liver regeneration. Conversely, in hepatocytes cultured conventionally on dried rat tail collagen (RTC) in the presence of EGF and insulin, which potentiate proliferation, GLUT-1 mRNA is rapidly and abundantly expressed, whereas GLUT-2 is depressed. To investigate the causes of this "switch" in glucose transporter expression seen when hepatocytes are removed from the liver and cultured under the conventional proliferative conditions, we examined the effects of specific growth factors and extracellular matrices on cultured hepatocytes. EGF, a potent liver mitogen, although causing a threefold induction of GLUT-1, was found to have no effect on GLUT-2 expression, suggesting that the increase in GLUT-2 seen in regenerating liver is not due to EGF. Inhibition of protein synthesis by cycloheximide in cultured hepatocytes does not prevent the induction of GLUT-1 mRNA. In addition, treatment of cells with cycloheximide appears to stabilize the GLUT-2 mRNA, preventing the usual down-regulation of this gene in cultured hepatocytes. The expression of the two glucose transporter mRNAs also differed when the hepatocytes were adherent to particular cell matrices. Culture of hepatocytes on a reconstituted basement membrane gel matrix (EHS) is known to restrain their growth and mediate high levels of differentiated hepatocytic functions that are lost under conventional culture conditions. Unlike cells on RTC, hepatocytes on EHS expressed low levels of GLUT-1 mRNA, and decreased GLUT-2 mRNA. TGF-beta, an attenuator of DNA synthesis, when added to cultures on RTC, substantially down-regulated GLUT-2 but had no effect on GLUT-1. We propose that the effectors, EGF, TGF-beta and basement membrane components, play a significant role in the regulation of expression of GLUT-1 and GLUT-2 in hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429849     DOI: 10.1002/jcp.1041530208

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

1.  Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.

Authors:  Donna S Dorow; Carleen Cullinane; Nelly Conus; Peter Roselt; David Binns; Timothy J McCarthy; Grant A McArthur; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

2.  CCAAT/enhancer binding protein regulates the promoter activity of the rat GLUT2 glucose transporter gene in liver cells.

Authors:  J W Kim; Y H Ahn
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

3.  Loss of intracellular lipid binding proteins differentially impacts saturated fatty acid uptake and nuclear targeting in mouse hepatocytes.

Authors:  Stephen M Storey; Avery L McIntosh; Huan Huang; Gregory G Martin; Kerstin K Landrock; Danilo Landrock; H Ross Payne; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-02       Impact factor: 4.052

4.  Normal tissue radioprotection by amifostine via Warburg-type effects.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Christos E Zois; Dimitra Kalamida; Stamatia Pouliliou; Ilias V Karagounis; Tzu-Lan Yeh; Martine I Abboud; Timothy D W Claridge; Christopher J Schofield; Efthimios Sivridis; Costantinos Simopoulos; Savvas P Tokmakidis; Adrian L Harris
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.